Dinner Industry Session†: One Patient’s Journey: Treating MDD with a Rapid-Acting Antidepressant That
Modulates Both Glutamatergic and Monoaminergic Pathways
Kristian Dambrino, DNP, APRN, PMHNP-BC and Todd Broder, MD
Sponsored by Axsome Therapeutics, Inc.